Showing results (161-170 of 205) with videos related to

Sort By:
Pageof 21
Retina (Philadelphia, Pa.)|February 17, 2022
THREE-YEAR TREATMENT OUTCOMES OF AFLIBERCEPT VERSUS RANIBIZUMAB FOR DIABETIC MACULAR EDEMA: Data from the Fight Retinal Blindness! RegistryPierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, et al.
Ophthalmology. Retina|March 21, 2022
Characterization of Poor Visual Outcomes of Diabetic Macular Edema: The Fight Retinal Blindness! ProjectJanika Shah, Vuong Nguyen, Adrian Hunt, et al.
The British Journal of Ophthalmology|March 20, 2016
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degenerationDaniel Barthelmes, Anna Campain, Phuc Nguyen, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2010
Nocturnal periodic breathing during acclimatization at very high altitude at Mount Muztagh Ata (7,546 m)Konrad E Bloch, Tsogyal D Latshang, Alexander J Turk, et al.
Ophthalmology. Retina|April 22, 2026
Real-World Outcomes in Neovascular AMD with Visit Gaps under Anti-VEGF Therapy: Data from the FRB! RegistryLaura Goncalves, Yohei Hashimoto, Daniel Barthelmes, et al.
The British Journal of Ophthalmology|September 25, 2014
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study dataDaniel Barthelmes, Richard Walton, Anna E Campain, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Genetic susceptibility to schizophrenia through neuroinflammatory pathways is associated with retinal thinning: Findings from the UK-BiobankFinn Rabe, Lukasz Smigielski, Foivos Georgiadis, et al.
Pageof 21